ArticleBMJ health & care informatics2026
Biomarkers associated with future suicide risk enhance predictive performance in psychiatric inpatients.
Article in BMJ health & care informatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
43 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectivesSuicide risk assessments currently rely on subjective clinical judgement, lacking objective measures. This study aimed to evaluate the association between biomarkers and suicide risk and to explore their predictive potential using machine learning (ML).
methodsWe analysed data from 2785 first-admission psychiatric inpatients across three institutions, including 103 biomarkers and 13 demographic and clinical variables. Suicide risk was assessed 1 week after admission using the Nurses' Global Assessment of Suicide Risk.
resultsA total of 2785 patients met the inclusion criteria, from which 978 were selected via propensity score matching to minimise confounding from demographic factors, treatment differences and symptom severity. Multivariate random effects logistic regression identified nine biomarkers associated with elevated suicide risk and six with potential protective effects. Time-trend analyses further revealed that nine biomarkers showed significant changes following risk escalation. Integrating biomarkers with demographic data, treatment information and psychological scale scores substantially improved ML model performance, achieving an area under the receiver operating characteristic curve of 0.808 in the external testing cohort. The inclusion of biomarkers significantly enhanced predictive accuracy.
conclusionThis study highlights the potential of biomarkers with ML to predict future risk, offering objective assessments and supporting early interventions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.